Darbepoetin, effective treatment of anaemia in paediatric patients with chronic renal failure

Darbepoetin alfa (DA) is a unique long-acting treatment for anaemia in patients with chronic renal failure (CRF). This study assessed the mean dose of DA to achieve and maintain haemoglobin (Hb) levels between 11 g/dl and 13 g/dl in CRF children aged 11 years to 18 years. This observational, prospec...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Pediatr Nephrol
Päätekijät: André, Jean-Luc, Deschênes, Georges, Boudailliez, Bernard, Broux, Françoise, Fischbach, Michel, Gagnadoux, Marie-France, Horen, Benjamin, Lahoche-Manucci, Annie, Macher, Marie-Alice, Roussel, Bernard, Tsimaratos, Michel, Loirat, Chantal
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer Berlin Heidelberg 2007
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6904385/
https://ncbi.nlm.nih.gov/pubmed/17216497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00467-006-0402-1
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia